LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Evaxion Biotech A/S…

Similar companies to Evaxion Biotech A/S

Evaxion Biotech A/S Tech Stack

Evaxion Biotech A/S uses 8 technology products and services including Ansible, Hudson, PyTorch, and more. Explore Evaxion Biotech A/S's tech stack below.

  • Ansible
    Configuration Management
  • Hudson
    Continuous Integration
  • PyTorch
    Machine Learning
  • Microsoft Azure
    Platform As A Service
  • Linux
    Programming Languages
  • Python
    Programming Languages
  • libvirt
    Virtualisation Software
  • Nginx
    Web Servers

Media & News

Evaxion Biotech A/S's Email Address Formats

Evaxion Biotech A/S uses at least 2 format(s):
Evaxion Biotech A/S Email FormatsExamplePercentage
Last@evaxion-biotech.comDoe@evaxion-biotech.com
65%
FL@evaxion-biotech.comJD@evaxion-biotech.com
35%
FL@evaxion.aiJD@evaxion.ai
100%

Frequently Asked Questions

Where is Evaxion Biotech A/S's headquarters located?

Minus sign iconPlus sign iconEvaxion Biotech A/S's main headquarters is located at 5f Drive Neergaards Vej Hørsholm, Hovedstaden 2970 Denmark. The company has employees across 3 continents, including EuropeNorth AmericaSouth America.

What is Evaxion Biotech A/S's official website and social media links?

Minus sign iconPlus sign iconEvaxion Biotech A/S's official website is evaxion.ai and has social profiles on LinkedInCrunchbase.

What is Evaxion Biotech A/S's SIC code NAICS code?

Minus sign iconPlus sign iconEvaxion Biotech A/S's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evaxion Biotech A/S have currently?

Minus sign iconPlus sign iconAs of February 2026, Evaxion Biotech A/S has approximately 56 employees across 3 continents, including EuropeNorth AmericaSouth America. Key team members include Cso / Interim Ceo: B. R.Chief Financial Officer: T. F. S.Chief Ai Officer, Founder: A. H. M.. Explore Evaxion Biotech A/S's employee directory with LeadIQ.

What industry does Evaxion Biotech A/S belong to?

Minus sign iconPlus sign iconEvaxion Biotech A/S operates in the Biotechnology Research industry.

What technology does Evaxion Biotech A/S use?

Minus sign iconPlus sign iconEvaxion Biotech A/S's tech stack includes AnsibleHudsonPyTorchMicrosoft AzureLinuxPythonlibvirtNginx.

What is Evaxion Biotech A/S's email format?

Minus sign iconPlus sign iconEvaxion Biotech A/S's email format typically follows the pattern of Last@evaxion-biotech.com. Find more Evaxion Biotech A/S email formats with LeadIQ.

How much funding has Evaxion Biotech A/S raised to date?

Minus sign iconPlus sign icon As of February 2026, Evaxion Biotech A/S has raised $4.1M in funding. The last funding round occurred on Jul 11, 2025 for $4.1M.

When was Evaxion Biotech A/S founded?

Minus sign iconPlus sign iconEvaxion Biotech A/S was founded in 2008.

Evaxion Biotech A/S

Biotechnology ResearchHovedstaden, Denmark51-200 Employees

Evaxion A/S is a pioneering TechBio company based upon its AI platform, AI-Immunology™. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology™, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-Immunology™ platform and vaccine pipeline, please visit our website.

Section iconCompany Overview

Headquarters
5f Drive Neergaards Vej Hørsholm, Hovedstaden 2970 Denmark
Website
evaxion.ai
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $4.1M

    Evaxion Biotech A/S has raised a total of $4.1M of funding over 8 rounds. Their latest funding round was raised on Jul 11, 2025 in the amount of $4.1M.

  • $1M

    Evaxion Biotech A/S's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $4.1M

    Evaxion Biotech A/S has raised a total of $4.1M of funding over 8 rounds. Their latest funding round was raised on Jul 11, 2025 in the amount of $4.1M.

  • $1M

    Evaxion Biotech A/S's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    B. R.
    Cso / Interim Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. F. S.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. H. M.
    Chief Ai Officer, Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. O. W.
    Vice President Clinical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. M.
    Vp Investor Relations
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    J. K.
    Vp, Ai & Innovation
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. C.
    Vice President, Infectious Disease Vaccine Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. F.
    Director, Head Of Business Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. S. J.
    Cmc Project Vp
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. M.
    Vp Investor Relations
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.